The Antibody Society, in collaboration with the Ovarian Cancer Research Alliance (OCRA), is pleased to present the Emerging Immunotherapeutics for Ovarian Cancer Symposium. The mission of OCRA is to cure ovarian cancer, advocate for patients, and support survivors. The aim of this event is to spread knowledge and awareness around current and up-and-coming basic and clinical research on the use of antibody and immune therapeutics for the treatment of ovarian cancer. See below for the expert speaker line-up, the event schedule and information about our corporate sponsors who will be exhibiting during the symposium.
We encourage registrants to donate to OCRA via this link to the Ovarian Cancer Research Alliance.